Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Immunization”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Testing effectiveness (Phase 2)Study completedNCT00135564
What this trial is testing

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Not applicableStudy completedNCT03824093
What this trial is testing

High and Low Resource Interventions to Promote HPV Vaccines

Who this might be right for
Human Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more
Children's Mercy Hospital Kansas City 225
Testing effectiveness (Phase 2)Study completedNCT00471081
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 385
Large-scale testing (Phase 3)Study completedNCT02986854
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 704
Testing effectiveness (Phase 2)Study completedNCT00560313
What this trial is testing

Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults

Who this might be right for
Meningococcal Disease
Novartis Vaccines 54
Large-scale testing (Phase 3)Study completedNCT00496015
What this trial is testing

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 750
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Large-scale testing (Phase 3)Study completedNCT01266993
What this trial is testing

Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children

Who this might be right for
Infections, MeningococcalMeningococcal Vaccines
GlaxoSmithKline 271
Post-approval studies (Phase 4)Study completedNCT02446691
What this trial is testing

Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 128
Testing effectiveness (Phase 2)Study completedNCT01272180
What this trial is testing

Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults

Who this might be right for
Invasive Meningococcal Disease
Novartis Vaccines 484
Not applicableStudy completedNCT02811120
What this trial is testing

PRIME Follow up - Quadri Meningo Vacinees

Who this might be right for
Meningococcal Disease
Public Health England 57
Post-approval studies (Phase 4)Study completedNCT02526394
What this trial is testing

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

Who this might be right for
PertussisMeningitisPreventive Immunization; Meningitis+1 more
Public Health England 400
Testing effectiveness (Phase 2)Study completedNCT00134719
What this trial is testing

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 1,104
Large-scale testing (Phase 3)Study completedNCT00317109
What this trial is testing

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 168
Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Large-scale testing (Phase 3)Study completedNCT04142242
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

Who this might be right for
Meningococcal Infection (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 471
Testing effectiveness (Phase 2)Study completedNCT04722003
What this trial is testing

Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination

Who this might be right for
Gonorrhoea
National Institute of Allergy and Infectious Diseases (NIAID) 52
Post-approval studies (Phase 4)Study completedNCT00581035
What this trial is testing

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 712
Testing effectiveness (Phase 2)Study completedNCT00381615
What this trial is testing

Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Who this might be right for
Healthy
Novartis Vaccines 147
Load More Results